ArticleEuropean journal of obstetrics & gynecology and reproductive biology: X2026
Risk factors for postoperative opioid prescription after benign hysterectomy.
Article in European journal of obstetrics & gynecology and reproductive biology: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify risk factors for dispensed opioid prescriptions after benign hysterectomy. Design: A nationwide register-based cohort study including 50,601 hysterectomies with complete data from the Swedish National Quality Register for Gynecological Surgery (GynOp). Data were linked to the Swedish National Drug Register, the National Patient Register, and Statistics Sweden. Logistic regression analyses were performed in three steps: adjusting for demographics, intraoperative factors, and postoperative complications. Results: Increasing age was associated with a lower risk of postoperative opioid dispensing (aRR 0.56 for >70 vs <50 years; 95% CI 0.49-0.64). Lower risk was also observed for hysterectomy due to prolapse (aRR 0.63; 95% CI 0.56-0.72) and cervical dysplasia (aRR 0.86; 95% CI 0.77-0.95). Modestly increased risks were found among patients using antihypertensive or cardiac medications (aRR 1.13; 95% CI 1.05-1.21), with previous cesarean section (aRR 1.10; 95% CI 1.05-1.16), BMI 30-39 (aRR 1.12; 95% CI 1.02-1.24), smoking (aRR 1.12; 95% CI 1.02-1.22), previous abdominal surgery (aRR 1.22; 95% CI 1.16-1.29), or previous vaginal surgery (aRR 1.15; 95% CI 1.06-1.24).Substantially increased risks were associated with preoperative psycholeptics (aRR 1.65; 95% CI 1.55-1.76), antidepressants (aRR 1.22; 95% CI 1.13-1.32), immunomodulators (aRR 1.45; 95% CI 1.11-1.90), endometriosis (aRR 1.58; 95% CI 1.36-1.83), open surgery (aRR 1.43; 95% CI 1.33-1.54), and postoperative complications (aRR 1.46; 95% CI 1.40-1.53). The strongest predictor was region: surgery in Stockholm was associated with more than double the risk (aRR 2.52). Conclusions: Postoperative opioid dispensing after benign hysterectomy is primarily driven by patient-related factors and regional prescribing practices. Despite increasing adoption of minimally invasive techniques, opioid dispensing rose by 8% annually from 2005 to 2022, underscoring the need for targeted strategies to reduce unnecessary postoperative opioid exposure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.